Last updated on July 2017

COAST: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiographic Axial Spondyloarthritis


Brief description of study

COAST: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiographic Axial Spondyloarthritis

Detailed Study Description

Local doctors are looking for people with Ankylosing Spondylitis (AS) for a clinical research study of an investigational drug. AS is a type of inflammatory arthritis that mostly affects the spine.

Clinical Study Identifier: TX151194

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Richard Robinson, BSN, RN, CCRC

The Osteoporosis & Clinical Trials Center
Hagerstown, MD USA
  Connect »